AUPS271902A0 - Gene expression and multiple sclerosis - Google Patents
Gene expression and multiple sclerosisInfo
- Publication number
- AUPS271902A0 AUPS271902A0 AUPS2719A AUPS271902A AUPS271902A0 AU PS271902 A0 AUPS271902 A0 AU PS271902A0 AU PS2719 A AUPS2719 A AU PS2719A AU PS271902 A AUPS271902 A AU PS271902A AU PS271902 A0 AUPS271902 A0 AU PS271902A0
- Authority
- AU
- Australia
- Prior art keywords
- gene expression
- multiple sclerosis
- sclerosis
- gene
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000014509 gene expression Effects 0.000 title 1
- 201000006417 multiple sclerosis Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS2719A AUPS271902A0 (en) | 2002-05-31 | 2002-05-31 | Gene expression and multiple sclerosis |
AU2003229114A AU2003229114A1 (en) | 2002-05-31 | 2003-06-02 | Gene expression and multiple sclerosis |
PCT/AU2003/000684 WO2003102227A1 (en) | 2002-05-31 | 2003-06-02 | Gene expression and multiple sclerosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS2719A AUPS271902A0 (en) | 2002-05-31 | 2002-05-31 | Gene expression and multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPS271902A0 true AUPS271902A0 (en) | 2002-06-20 |
Family
ID=3836282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPS2719A Abandoned AUPS271902A0 (en) | 2002-05-31 | 2002-05-31 | Gene expression and multiple sclerosis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPS271902A0 (en) |
WO (1) | WO2003102227A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2414775A1 (en) | 2000-05-03 | 2001-11-08 | Expressive Constructs, Inc. | A method and device for improving protein stability and solubility |
EP1624886A2 (en) * | 2003-05-12 | 2006-02-15 | Expressive Constructs, Inc. | Methods for increasing cell and tissue viability |
WO2006097463A2 (en) * | 2005-03-15 | 2006-09-21 | Ares Trading S.A. | Compositions and methods for treating and diagnosing inflammatory disorders |
WO2007071437A2 (en) * | 2005-12-22 | 2007-06-28 | Ares Trading S.A. | Compositions and methods for treating inflammatory disorders |
EP2121971B1 (en) * | 2006-12-29 | 2011-03-30 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Methods and kits for diagnosis of multiple sclerosis in probable multiple sclerosis subjects |
CA2706849A1 (en) * | 2007-11-28 | 2009-06-04 | Redoxis Aktiebolag | New treatment of autoimmune conditions |
JP5833924B2 (en) | 2008-09-19 | 2015-12-16 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | Methods for identification and prediction of multiple sclerosis and therapeutic response |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69737815T2 (en) * | 1996-01-30 | 2008-03-06 | The Scripps Research Institute, La Jolla | G-PROTEIN COUPLED RECEPTOR WITH ENLARGED, EXTRA-CELLULAR DOMAIN |
US5834238A (en) * | 1997-04-08 | 1998-11-10 | Incyte Pharmaceuticals, Inc. | Human GTP binding protein |
US6190909B1 (en) * | 1997-04-17 | 2001-02-20 | Millennium Pharmaceuticals, Inc. | TH2-specific gene |
US5874248A (en) * | 1997-08-21 | 1999-02-23 | Incyte Pharmaceuticals, Inc. | Glutathione S-transferase homolog |
US5919627A (en) * | 1997-10-29 | 1999-07-06 | Incyte Pharmaceuticals, Inc. | Microsomal glutathione-S-transferase |
US6030809A (en) * | 1997-11-25 | 2000-02-29 | Incyte Pharmaceuticals, Inc. | Glutathione S-transferase |
US5945306A (en) * | 1997-12-16 | 1999-08-31 | Incyte Pharmaceuticals, Inc. | Ras protein |
AU2982799A (en) * | 1998-03-03 | 1999-09-20 | Zymogenetics Inc. | Human semaphorin zsmf-7 |
US6660476B2 (en) * | 2000-05-02 | 2003-12-09 | City Of Hope | Polymorphisms in the PNMT gene |
WO2002048326A2 (en) * | 2000-12-14 | 2002-06-20 | Bayer Aktiengesellschaft | Human caplain proteins and polynucleotides coding therefor |
CA2479780A1 (en) * | 2001-04-04 | 2002-10-17 | Universite De Montreal | Antisense calpain nucleotides and uses thereof |
-
2002
- 2002-05-31 AU AUPS2719A patent/AUPS271902A0/en not_active Abandoned
-
2003
- 2003-06-02 WO PCT/AU2003/000684 patent/WO2003102227A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003102227A1 (en) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002234755A1 (en) | Interferon-alpha induced gene | |
AU2003267036A1 (en) | Tubulysin biosynthesis gene | |
AU2003211367A1 (en) | Novel dehydrogenase and gene encoding the same | |
AUPS271902A0 (en) | Gene expression and multiple sclerosis | |
AU2003231827A1 (en) | Pseudo-tissues and uses thereof | |
AU2003302173A1 (en) | Spirotetrathiocarbamates and spirooxothiocarbamates | |
AU2003295311A1 (en) | Caterpiller gene family | |
AU2003239589A1 (en) | Eta-1 gene and methods for use | |
AU2003294705A1 (en) | NtSM GENE | |
AU2002953015A0 (en) | Modified lacz gene | |
AU2003229114A1 (en) | Gene expression and multiple sclerosis | |
AU2003267790A1 (en) | Lipase inhibitors and uses thereof | |
AUPR295001A0 (en) | A gene and uses therefor | |
AU2003228397A1 (en) | HAUSP-p53 INTERACTION AND USES THEREOF | |
AU2003297297A1 (en) | Elf3 gene compositions and methods | |
AU2003292721A1 (en) | Novel protein and its gene | |
AU2003252991A1 (en) | INTERFERON-Alpha INDUCED GENE | |
AU2003216442A1 (en) | Enkurin and uses thereof | |
AU2003267384A1 (en) | Bhyd gene | |
AU2002310591A1 (en) | Interferon-alpha induced gene | |
AU2003284640A1 (en) | Type 2 diabetes-associated gene | |
AU2003220853A1 (en) | Abc transporter-associated gene abcc13 | |
AUPR513701A0 (en) | A gene and uses therefor | |
AU2003203240A1 (en) | Novel phospholipase a2 and gene thereof | |
AUPS079702A0 (en) | Genetic sequence and uses therefor |